You are on page 1of 18

Equity Research

14 March 2014

U.S. Consumer Finance

Purchase Origination Outlook Is Better than Feared
Over the past few weeks, we have fielded many calls regarding the decline in the MBA Purchase Applications Index and the potential read-through to purchase originations. We analyzed nearly 25 years of applications data and found a breakdown in the correlation between purchase applications and both purchase originations and home sales. We also studied the impact of severe winter weather in different geographic regions and believe that an unseasonably cold/extreme winter could be a key driver weakness in 1Q14 purchase data. Due to this magnified winter seasonality, we caution investors against extrapolating weakness in 1Q purchase data as a gauge of home buyer sentiment. We remain bullish on purchase origination growth and expect both the title insurers and the mortgage insurers to benefit. MBA Purchase Application Correlations Have Broken Down Significantly: While refi correlations have held up well over time, the MBA purchase application index has experienced a correlation breakdown to both purchase mortgage originations and home sales volumes. From 1990 through 3Q07, the correlation between purchase applications both purchase originations and the volume of new and existing homes sold were above 90%, indicating a very strong relationship. Since the crisis, however, that correlation has broken down, with a ~60% correlation to both purchase originations and sales volumes since 1Q10, with the index showing applications were mostly flat during that stretch while purchase originations climbed steadily higher. We therefore caution investors against putting too much weight on the applications index as a read through to originations. Extreme Winter Weather is Magnifying Seasonality: While the winter months are seasonally weak for purchase originations, we believe that seasonality has been magnified by extreme winter weather during 1Q14. During January and February, snowstorms and unseasonably cold temperatures have disproportionately impacted the southern regions of the U.S., which historically account for over 40% of home sales during the winter months. In our view, weakness in the purchase data (and likely y/y declines in purchase originations) is mainly traceable to extreme winter weather rather than the beginning of any longer term trend. Title Insurers and MIs Stand to Benefit Longer Term: With the MIs having 3x the penetration to purchase originations vs. refi originations and title insurers generating 2x the earnings on a purchase order vs. a refi order, the continued recovery in the purchase market should benefit ESNT, FNF, and FAF more than any other names in our coverage universe. While we expect 1Q14 purchase originations will be quite weak due to the combination of normal seasonality and extreme winter weather, we believe the outlook for the remainder of the year is better than the latest application data suggests because of this breakdown in correlation.

INDUSTRY UPDATE U.S. Consumer Finance

POSITIVE
Unchanged U.S. Consumer Finance Mark C. DeVries 1.212.526.9484 mark.devries@barclays.com BCI, New York Jeremy Campbell, CFA 1.212.526.9750 jeremy.campbell@barclays.com BCI, New York

Barclays Capital Inc. and/or one of its affiliates does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. PLEASE SEE ANALYST CERTIFICATION(S) AND IMPORTANT DISCLOSURES BEGINNING ON PAGE 8.

Barclays | U.S. Consumer Finance

MBA Applications Index: Broken Correlation to Purchase Activity, Refi Still Solid
Over the past few weeks, we have fielded many questions regarding the potential impact of weak MBA applications data on the mortgage market. One key takeaway from our analysis of nearly 25 years of data is that the correlation between purchase applications and purchase originations (each measured by the MBA) has broken down significantly since the financial crisis. As showcased in Figure 1, while the correlation between the MBA’s refi application index (NSA) and refi originations has held up well over time, the MBA purchase application index (NSA) has experienced a correlation breakdown to both purchase mortgage originations and home sales volumes. From 1990 through 3Q07, the correlation between purchase applications both purchase originations and the volume of new and existing homes sold were above 90%, indicating a very strong relationship. Since the crisis, however, that correlation has broken down, with a ~60% correlation to both purchase originations and sales volumes since 1Q10. FIGURE 1 Correlation Analysis: MBA Applications Indices vs. Mortgage Originations and Home Sales Volume (both New & Existing)
Refi Apps (NSA) to Refi Originations 1990 - Present 1990 - 3Q07 4Q07 - Present 1Q10 - Present 87.4% 93.5% 85.8% 92.7% Purchase Apps (NSA) Purchase Apps (NSA) to Home Sales to Purchase Volume Originations 92.6% 96.4% 64.3% 57.8% 82.8% 90.6% 14.7% 60.2%

Source: Mortgage Bankers Association, U.S. Census Bureau, National Association of Realtors, Barclays Research Note: Mortgage originations come from the MBA for consistency purposes

Over the past few years, purchase originations have showcased continued momentum with an average y/y growth rate of ~15% for each quarter since 2H11 while, over that same time period, the MBA’s non-seasonally adjusted purchase index only averaged ~2.5% y/y growth (Figure 3). In our view, one reason for this breakdown is that purchase applications track an application for a purchase transaction while mortgage originations are comprised of both the number of transactions and the value of the homes purchased. Thus, volatility in home price appreciation (HPA) levels, as seen over the past few years, could contribute to at least some of the correlation breakdown. If HPA volatility were the primary driver of a correlation breakdown, however, we would expect a strong correlation between the MBA purchase applications index and the volume of homes sold. However, over the same time period in which the MBA’s NSA purchase application index was up ~2.5%, the number of homes sold in the U.S. was up an average of ~10% on a y/y basis (Figure 5). While we aren’t sure if 1Q14 purchase originations will deviate significantly from the applications index (down 20% y/y in 1Q14 thus far), we do believe that extrapolating a decline in the applications index during a seasonally weak quarter is likely misguided. Thus, due to the correlation breakdown between purchase applications and originations/home sales, we caution investors from putting too much emphasis on MBA purchase application data as a read through to purchase originations in 2014.

14 March 2014

2

Barclays | U.S. Consumer Finance

FIGURE 2 MBA Purchase Application Index (NSA) vs. MBA Purchase Originations ($bn)

FIGURE 3 Y/Y Change in MBA Purchase Application Index (NSA) vs. Y/Y Change in MBA Purchase Originations

250 200 150

40% 20% 0% ‐20%

100 50
Mar‐10 Jun‐10 Sep‐10 Dec‐10 Mar‐11 Jun‐11 Sep‐11 Dec‐11 Mar‐12 Jun‐12 Sep‐12 Dec‐12 Mar‐13 Jun‐13 Sep‐13 Dec‐13 Mar‐14

‐40% ‐60%

Purch Orig ($bn)

Purch App Index, NSA

Y/Y Chg Purch Orig

Y/Y Chg Purch App Idx, NSA

Source: Mortgage Bankers Association, Barclays Research

Source: Mortgage Bankers Association, Barclays Research

FIGURE 4 MBA Purchase Application Index (NSA) vs. Home Sales Volumes (both New & Existing)

FIGURE 5 Y/Y Change in MBA Purchase Application Index (NSA) vs. Y/Y Change in Home Sales Volumes (both New & Existing)

250 1,300 1,100 900 700 500 225 200 175 150 125 100

20% 10% 0% ‐10% ‐20% ‐30% ‐40%

Home Sales Vol

Purchase App Index, NSA

Y/Y Chg Sales Vol

Y/Y Chg Purch App Idx, NSA

Source: U.S. Census Bureau, National Association of Realtors, Barclays Research

Source: U.S. Census Bureau, National Association of Realtors, Barclays Research

14 March 2014

3

Barclays | U.S. Consumer Finance

FIGURE 6 MBA Refi Application Index (NSA) vs. MBA Refi Originations ($bn)

FIGURE 7 Y/Y Change in MBA Refi Application Index (NSA) vs. Y/Y Change in MBA Refi Originations

500 400 300 200 100 0

5,000 4,000 3,000 2,000 1,000 0

150% 125% 100% 75% 50% 25% 0% ‐25% ‐50% ‐75%

Refi Orig ($bn, lhs)

Refi App Index, NSA (rhs)

Y/Y Chg Refi Orig.

Y/Y Chg Refi App Index, NSA

Source: Mortgage Bankers Association, Barclays Research

Source: Mortgage Bankers Association, Barclays Research

Extreme Winter Weather is a Likely Contributor to Weak Purchase Data
While winter weather has been blamed for all sorts of ills (a weak jobs report, softness in retail spending, and Syracuse basketball’s losing streak), we think that it is likely that extreme winter weather in January and February adversely impacted home purchase data. While purchase originations are seasonally weak in the first quarter of the year, we believe that the extreme winter weather experienced by significant portions of the country have exacerbated that seasonality. As showcased in Figure 8, over 40% of the homes sold in the U.S are traceable to the southern states. Furthermore, the South’s share of home sales increases in the winter months (~42%) as potential buyers in the Midwest and the Northeast are more inclined to wait for the spring selling season. FIGURE 8 U.S. Home Sales (Existing & New) by Region (2004-2013)
Midwest Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Annl. Avg 20.2% 22.8% 22.9% 22.6% 24.2% 23.5% 23.6% 22.8% 23.4% 21.9% 21.4% 22.3% 22.6% Northeast 11.3% 12.7% 11.6% 11.9% 11.2% 12.3% 13.3% 12.7% 12.1% 12.3% 11.8% 11.5% 12.0% South 42.0% 41.0% 40.7% 40.4% 39.9% 40.1% 40.3% 41.5% 41.5% 41.8% 41.4% 42.2% 41.1% West 26.5% 23.5% 24.8% 25.0% 24.7% 24.1% 22.8% 23.0% 22.9% 24.0% 25.4% 24.0% 24.3%

Source: U.S. Census Bureau, National Association of Realtors, Barclays Research

14 March 2014

4

Barclays | U.S. Consumer Finance However, unlike previous winters, the southern region of the U.S. experienced both unseasonably cold weather and an high number of individuals impacted by severe winter storms. The National Oceanic & Atmospheric Administration (NOAA) tracks severe snowstorms for the eastern two thirds of the U.S. through its Regional Snowfall Index (RSI), grading storms based on their impact in each region from “notable” to “Crippling” or “Extreme” (Figure 9). FIGURE 9 Over 4x as Many People in the Southern U.S. have been Impacted by Severe Winter Weather in 2014 than in 2012 and 2013 Combined
National Oceanic & Atmospheric Administration Description Notable Significant Major Crippling Extreme RSI Value 1–3 3–6 6–10 10–18 18.0+ Avg RSI 2014 Feb Northeast Ohio Valley Southeast Jan Northeast Northern Rockies and Plains Ohio Valley South Southeast Upper Midwest 2013 Feb Northeast Northern Rockies and Plains Ohio Valley South Upper Midwest Jan Northern Rockies and Plains Upper Midwest 2012 Feb Northern Rockies and Plains Jan Northeast Ohio Valley Upper Midwest
Source: NOAA, Barclays Research

Population Impacted (mm) 267.9 96.7 59.1 10.9 26.8 171.2 59.0 4.2 42.8 10.8 31.3 23.1 298.6 271.2 58.8 7.0 80.5 16.5 108.4 27.4 4.0 23.3 124.9 3.1 3.1 121.9 53.4 45.0 23.5

5.8 4.4 2.5 10.7 1.4 1.3 1.1 1.5 1.4 1.6 1.5 3.6 10.1 2.2 1.6 8.2 1.7 1.6 1.5 1.6 2.8 2.8 1.4 1.1 1.1 1.9

Population Impacted (mm) South/Southeast 68.9 26.8

26.8 42.1

10.8 31.3 16.5 16.5

16.5 0.0

0.0 0.0 0.0

While winter storms have impacted a great number of people nationwide over the past two years, the NOAA’s data shows an increased level of winter weather disruptions in geographies that are less equipped to deal with snowstorms in 2014. As shown in Figure 9, over 4x as many people in the southern U.S. have been impacted by snowstorms in 2014
14 March 2014 5

Barclays | U.S. Consumer Finance than in both 2012 and 2013 combined. Therefore, in 2014, the geographic region responsible for a significant portion of home sales experienced a significantly larger impact from winter weather, suggesting that some of the weakness in purchase applications (and possibly 1Q14 originations) could stem from snowstorm related impacts. Furthermore, in addition to the impact from snowstorms, this winter has been unseasonably cold nationwide. According to the NOAA data, average temperatures have been ~2-4 degrees below the historic averages in 2014 on a national scale (Figure 11). As indicated in Figure 10, the southern regions of the U.S. experienced unseasonably cold temperatures relative to historical norms and recent years.

FIGURE 10 Deviation of January and February National Temperatures from Historic Averages (1990-2010) by Region: Cold Weather was More Extreme and More Pervasive than Recent Years

FIGURE 11 Deviation of January and February National Temperatures from Historic Averages (1990-2010): 2014 was Unseasonably Cold Relative to both Recent Years and Historical Norms

2014 National Average Northeast Northern Rockies and Plains Upper Midwest Ohio Valley Southeast South Southwest West Northwest 2013 National Average Northeast Northern Rockies and Plains Upper Midwest Ohio Valley Southeast South Southwest West Northwest 2012 National Average Northeast Northern Rockies and Plains Upper Midwest Ohio Valley Southeast South Southwest West Northwest
Source: NOAA, Barclays Research

Deviation from Avg. Temp. January February (1.8) (3.6) (4.5) (3.9) 1.3 (8.3) (7.7) (11.2) (7.6) (7.8) (6.2) 0.1 (3.5) (4.3) 1.7 2.0 5.5 3.4 (1.7) 2.8 January February (0.1) (1.0) 1.8 0.2 0.4 0.7 1.8 (2.0) 2.2 (1.6) 4.4 (0.8) 1.3 (0.4) (4.6) (3.6) (3.8) (1.5) (3.7) (0.3) February January 3.8 1.7 3.6 5.5 5.6 1.0 6.4 6.2 4.3 3.6 2.9 3.1 4.0 1.3 2.8 (0.9) 2.5 (0.3) 0.8 (0.5)

4.0 3.0 2.0 1.0 0.0 (1.0) (2.0) (3.0) (4.0)

3.8

1.7

(0.1) (1.0) (1.8)

(3.6)

2012 January

2013

2014 February

Source: NOAA, Barclays Research

14 March 2014

6

Barclays | U.S. Consumer Finance

While there are many aspects of the economy that can be handled indoors (online shopping) or may benefit from winter weather (tourism and travel), home purchases are unique in that they require a potential buyer to physically go out and shop for real property. While this seasonality is always apparent in the home purchase and purchase origination data, we believe that the extreme winter weather of 2014 magnified the seasonal phenomenon due the disproportionately large impact on the southern region, which comprises a disproportionately large portion of the purchase market during the winter months.

Bullish Purchase Thesis Not Impacted by 1Q14 Weakness
Despite 1Q14 being a seasonally weak quarter for purchase originations, many clients have been concerned about the potential impact of declining MBA applications or weak 1Q14 purchase originations on both the title insurers and mortgage insurers. We caution investors from putting too much emphasis on MBA applications data due to both the breakdown in the purchase application/origination relationship and magnified winter seasonality from winter storms. Additionally, while we aren’t bullish on 1Q14 purchase originations, we do not think that weakness in 1Q14 applications or originations are a good indicator for buyer appetite in 2014. We remain bullish on continued strength in the purchase market and believe that both the title insurers and the mortgage insurers will stand to benefit.

14 March 2014

7

Barclays | U.S. Consumer Finance

ANALYST(S) CERTIFICATION(S):
I, Mark C. DeVries, hereby certify (1) that the views expressed in this research report accurately reflect my personal views about any or all of the subject securities or issuers referred to in this research report and (2) no part of my compensation was, is or will be directly or indirectly related to the specific recommendations or views expressed in this research report.

IMPORTANT DISCLOSURES CONTINUED
Barclays Research is a part of the Corporate and Investment Banking division of Barclays Bank PLC and its affiliates (collectively and each individually, "Barclays"). For current important disclosures regarding companies that are the subject of this research report, please send a written request to: Barclays Research Compliance, 745 Seventh Avenue, 14th Floor, New York, NY 10019 or refer to http://publicresearch.barclays.com or call 212-526-1072. The analysts responsible for preparing this research report have received compensation based upon various factors including the firm's total revenues, a portion of which is generated by investment banking activities. Analysts regularly conduct site visits to view the material operations of covered companies, but Barclays policy prohibits them from accepting payment or reimbursement by any covered company of their travel expenses for such visits. In order to access Barclays Statement regarding Research Dissemination Policies and Procedures, please refer to https://live.barcap.com/publiccp/RSR/nyfipubs/disclaimer/disclaimer-research-dissemination.html. In order to access Barclays Research Conflict Management Policy Statement, please refer to: http://group.barclays.com/corporates-and-institutions/research/research-policy. The Corporate and Investment Banking division of Barclays produces a variety of research products including, but not limited to, fundamental analysis, equity-linked analysis, quantitative analysis, and trade ideas. Recommendations contained in one type of research product may differ from recommendations contained in other types of research products, whether as a result of differing time horizons, methodologies, or otherwise. Primary Stocks (Ticker, Date, Price) Essent Group (ESNT, 13-Mar-2014, USD 23.40), Overweight/Positive, A/C/D/J/L Fidelity National Financial (FNF, 13-Mar-2014, USD 31.49), Overweight/Positive, A/C/D/J/K/L/M/N/O First American Financial (FAF, 13-Mar-2014, USD 27.36), Overweight/Positive, C/D/J/K/L/M/N/O MGIC Investment (MTG, 13-Mar-2014, USD 8.63), Overweight/Positive, A/C/D/J/L Radian Group (RDN, 13-Mar-2014, USD 15.18), Overweight/Positive, C/J/K/N/O

Disclosure Legend: A: Barclays Bank PLC and/or an affiliate has been lead manager or co-lead manager of a publicly disclosed offer of securities of the issuer in the previous 12 months. B: An employee of Barclays Bank PLC and/or an affiliate is a director of this issuer. C: Barclays Bank PLC and/or an affiliate is a market-maker and/or liquidity provider in equity securities issued by this issuer or one of its affiliates. D: Barclays Bank PLC and/or an affiliate has received compensation for investment banking services from this issuer in the past 12 months. E: Barclays Bank PLC and/or an affiliate expects to receive or intends to seek compensation for investment banking services from this issuer within the next 3 months. F: Barclays Bank PLC and/or an affiliate beneficially owned 1% or more of a class of equity securities of the issuer as of the end of the month prior to the research report's issuance. G: One of the analysts on the coverage team (or a member of his or her household) owns shares of the common stock of this issuer. H: This issuer beneficially owns 5% or more of any class of common equity securities of Barclays Bank PLC. I: Barclays Bank PLC and/or an affiliate has a significant financial interest in the securities of this issuer. J: Barclays Bank PLC and/or an affiliate trades regularly in the securities of this issuer. K: Barclays Bank PLC and/or an affiliate has received non-investment banking related compensation from this issuer within the past 12 months. L: This issuer is, or during the past 12 months has been, an investment banking client of Barclays Bank PLC and/or an affiliate. M: This issuer is, or during the past 12 months has been, a non-investment banking client (securities related services) of Barclays Bank PLC and/or an affiliate. N: This issuer is, or during the past 12 months has been, a non-investment banking client (non-securities related services) of Barclays Bank PLC and/or an affiliate. O: Barclays Capital Inc., through Barclays Market Makers, is a Designated Market Maker in this issuer's stock, which is listed on the New York Stock Exchange. At any given time, its associated Designated Market Maker may have "long" or "short" inventory position in the stock; and its associated Designated Market Maker may be on the opposite side of orders executed on the floor of the New York Stock Exchange in the stock. P: A partner, director or officer of Barclays Capital Canada Inc. has, during the preceding 12 months, provided services to the subject company for remuneration, other than normal course investment advisory or trade execution services. Q: The Corporate and Investment Banking division of Barclays Bank PLC, is a Corporate Broker to this issuer. 14 March 2014 8

Barclays | U.S. Consumer Finance

IMPORTANT DISCLOSURES CONTINUED
R: Barclays Capital Canada Inc. and/or an affiliate has received compensation for investment banking services from this issuer in the past 12 months. S: Barclays Capital Canada Inc. is a market-maker in an equity or equity related security issued by this issuer.

Guide to the Barclays Fundamental Equity Research Rating System: Our coverage analysts use a relative rating system in which they rate stocks as Overweight, Equal Weight or Underweight (see definitions below) relative to other companies covered by the analyst or a team of analysts that are deemed to be in the same industry (the "industry coverage universe"). In addition to the stock rating, we provide industry views which rate the outlook for the industry coverage universe as Positive, Neutral or Negative (see definitions below). A rating system using terms such as buy, hold and sell is not the equivalent of our rating system. Investors should carefully read the entire research report including the definitions of all ratings and not infer its contents from ratings alone. Stock Rating Overweight - The stock is expected to outperform the unweighted expected total return of the industry coverage universe over a 12-month investment horizon. Equal Weight - The stock is expected to perform in line with the unweighted expected total return of the industry coverage universe over a 12month investment horizon. Underweight - The stock is expected to underperform the unweighted expected total return of the industry coverage universe over a 12-month investment horizon. Rating Suspended - The rating and target price have been suspended temporarily due to market events that made coverage impracticable or to comply with applicable regulations and/or firm policies in certain circumstances including where the Corporate and Investment Banking Division of Barclays is acting in an advisory capacity in a merger or strategic transaction involving the company. Industry View Positive - industry coverage universe fundamentals/valuations are improving. Neutral - industry coverage universe fundamentals/valuations are steady, neither improving nor deteriorating. Negative - industry coverage universe fundamentals/valuations are deteriorating. Below is the list of companies that constitute the "industry coverage universe": U.S. Consumer Finance American Capital Agency (AGNC) Apollo Investment Corp. (AINV) Capitala Finance Corp. (CPTA) CIT Group, Inc. (CIT) Essent Group (ESNT) Fifth Street Senior Floating Rate Corp. (FSFR) Home Loan Servicing Solutions Ltd. (HLSS) JGWPT Holdings Inc. (JGW) Ocwen Financial Corp. (OCN) Radian Group (RDN) Springleaf Holdings Inc. (LEAF) Two Harbors Investment Corp. (TWO) Distribution of Ratings: Barclays Equity Research has 2598 companies under coverage. 45% have been assigned an Overweight rating which, for purposes of mandatory regulatory disclosures, is classified as a Buy rating; 46% of companies with this rating are investment banking clients of the Firm. 38% have been assigned an Equal Weight rating which, for purposes of mandatory regulatory disclosures, is classified as a Hold rating; 43% of companies with this rating are investment banking clients of the Firm. 15% have been assigned an Underweight rating which, for purposes of mandatory regulatory disclosures, is classified as a Sell rating; 39% of companies with this rating are investment banking clients of the Firm. Guide to the Barclays Research Price Target: Each analyst has a single price target on the stocks that they cover. The price target represents that analyst's expectation of where the stock will trade in the next 12 months. Upside/downside scenarios, where provided, represent potential upside/potential downside to each analyst's price target over the same 12-month period. American Express (AXP) Ares Capital Corp. (ARCC) Cherry Hill Mortgage Investment Corp. (CHMI) CYS Investments Inc. (CYS) Fidelity National Financial (FNF) First American Financial (FAF) Invesco Mortgage Capital Inc. (IVR) Medley Capital Corp. (MCC) OFS Capital Corp. (OFS) Santander Consumer USA Holdings, Inc. (SC) Stonegate Mortgage Corp. (SGM) Whitehorse Finance Inc. (WHF) Annaly Capital Management Inc. (NLY) ARMOUR Residential REIT Inc. (ARR) Chimera Investment Corp. (CIM) Discover Financial Services (DFS) Fifth Street Finance Corp. (FSC) Five Oaks Investment Corporation (OAKS) JAVELIN Mortgage Investment (JMI) MGIC Investment (MTG) Prospect Capital Corp. (PSEC) SLM Corp. (SLM) TICC Capital Corp. (TICC) ZAIS Financial Corp. (ZFC)

14 March 2014

9

Barclays | U.S. Consumer Finance

IMPORTANT DISCLOSURES CONTINUED
Barclays offices involved in the production of equity research: London Barclays Bank PLC (Barclays, London) New York Barclays Capital Inc. (BCI, New York) Tokyo Barclays Securities Japan Limited (BSJL, Tokyo) São Paulo Banco Barclays S.A. (BBSA, São Paulo) Hong Kong Barclays Bank PLC, Hong Kong branch (Barclays Bank, Hong Kong) Toronto Barclays Capital Canada Inc. (BCCI, Toronto) Johannesburg Absa Bank Limited (Absa, Johannesburg) Mexico City Barclays Bank Mexico, S.A. (BBMX, Mexico City) Taiwan Barclays Capital Securities Taiwan Limited (BCSTW, Taiwan) Seoul Barclays Capital Securities Limited (BCSL, Seoul) Mumbai Barclays Securities (India) Private Limited (BSIPL, Mumbai) Singapore Barclays Bank PLC, Singapore branch (Barclays Bank, Singapore)

14 March 2014

10

Barclays | U.S. Consumer Finance

IMPORTANT DISCLOSURES CONTINUED

Essent Group (ESNT)
USD 23.40 (13-Mar-2014) Rating and Price Target Chart - USD (as of 13-Mar-2014)

Stock Rating OVERWEIGHT Currency=USD Date 25-Nov-2013 Closing Price 21.40 Rating Overweight

Industry View POSITIVE

Adjusted Price Target 31.00

32

Source: Thomson Reuters, Barclays Research Historical stock prices and price targets may have been adjusted for stock splits and dividends.

30

28

26

24

22

20

Nov- 2013

Dec- 2013 Closing Price

Jan- 2014

Feb- 2014

Mar- 2014

Target Price

Rating Change

Source: IDC, Barclays Research

Link to Barclays Live for interactive charting
A: Barclays Bank PLC and/or an affiliate has been lead manager or co-lead manager of a publicly disclosed offer of securities of Essent Group in the previous 12 months. C: Barclays Bank PLC and/or an affiliate is a market-maker and/or liquidity provider in equity securities issued by Essent Group or one of its affiliates. D: Barclays Bank PLC and/or an affiliate has received compensation for investment banking services from Essent Group in the past 12 months. J: Barclays Bank PLC and/or an affiliate trades regularly in the securities of Essent Group. L: Essent Group is, or during the past 12 months has been, an investment banking client of Barclays Bank PLC and/or an affiliate. Valuation Methodology: Our $31 price target is based on a discounted earnings model that reflects 30+% top line growth through 2020 and a 15% top line CAGR through 2030 due to the high growth nature of the company Risks which May Impede the Achievement of the Barclays Research Price Target: Essent primarily insures mortgages that are sold to the GSE's, so any substantial reform of Fannie Mae and/or Freddie Mac could materially impact Essent's business. If FHA reform makes government insurance more attractive than private mortgage insurance, Essent's business could be adversely affected. We note, however, that FHA reform will likely increase the cost of government mortgage insurance relative to PMI, allowing private mortgage insurers to benefit. If the QRM definition requires a high down payment with no credit given for mortgage insurance, the mortgage insurance industry, including Essent, would see earnings degradation. Currently, however, it seems likely that QRM will match QM and not incorporate any significant down payment requirements. Although the company has risk mitigation controls in place and mortgages underwritten have strong credit characteristics, Essent is still subject to credit risk. Earnings could trail expectations if losses exceed management's projections. The U.S. housing market has primarily been dependent on supportive Fed policy over the past several years. Any major changes to the Fed's monetary policy and/or quantitative easing could affect Essent's operations and growth initiatives. Despite undertaking diversification initiatives over the past several years, Essent's customer base remains relatively concentrated, and the loss of one or more large customers could adversely affect Essent's ability to write new business.

14 March 2014

11

Barclays | U.S. Consumer Finance

IMPORTANT DISCLOSURES CONTINUED

Fidelity National Financial (FNF)
USD 31.49 (13-Mar-2014) Rating and Price Target Chart - USD (as of 13-Mar-2014)

Stock Rating OVERWEIGHT Currency=USD Date 07-Jan-2014 Closing Price 31.98 27.58 24.38 23.35 23.03 22.90 22.52 16.27 Overweight Rating

Industry View POSITIVE

Adjusted Price Target 39.00 32.00 28.00 26.00 28.00 21.00 18.00 17.00

40

25-Oct-2013 07-Aug-2013 10-Jul-2013

35

30

19-Dec-2012 19-Nov-2012 09-Oct-2012 27-Jul-2011

25

20

Source: Thomson Reuters, Barclays Research Historical stock prices and price targets may have been adjusted for stock splits and dividends.

15

10 Jul- 2011 Jan- 2012 Closing Price Jul- 2012 Jan- 2013 Jul- 2013 Rating Change Jan- 2014

Target Price

Source: IDC, Barclays Research

Link to Barclays Live for interactive charting
A: Barclays Bank PLC and/or an affiliate has been lead manager or co-lead manager of a publicly disclosed offer of securities of Fidelity National Financial in the previous 12 months. C: Barclays Bank PLC and/or an affiliate is a market-maker and/or liquidity provider in equity securities issued by Fidelity National Financial or one of its affiliates. D: Barclays Bank PLC and/or an affiliate has received compensation for investment banking services from Fidelity National Financial in the past 12 months. J: Barclays Bank PLC and/or an affiliate trades regularly in the securities of Fidelity National Financial. K: Barclays Bank PLC and/or an affiliate has received non-investment banking related compensation from Fidelity National Financial within the past 12 months. L: Fidelity National Financial is, or during the past 12 months has been, an investment banking client of Barclays Bank PLC and/or an affiliate. M: Fidelity National Financial is, or during the past 12 months has been, a non-investment banking client (securities related services) of Barclays Bank PLC and/or an affiliate. N: Fidelity National Financial is, or during the past 12 months has been, a non-investment banking client (non-securities related services) of Barclays Bank PLC and/or an affiliate. O: Barclays Capital Inc., through Barclays Market Makers, is a Designated Market Maker in Fidelity National Financial stock, which is listed on the New York Stock Exchange. At any given time, its associated Designated Market Maker may have "long" or "short" inventory position in the stock; and its associated Designated Market Maker may be on the opposite side of orders executed on the floor of the New York Stock Exchange in the stock. Valuation Methodology: Our $39 price target is reached by applying a 12x multiple to our normalized EPS estimate of $4.73 and discounting it at a 10% cost of equity over a 5 year time horizon until normalized earnings are reached. Risks which May Impede the Achievement of the Barclays Research Price Target: Interest rate risk: mortgage interest rates affect the level of real estate activities, which in turn affect FNF's earnings.Claim loss risks: claim losses associated with issuing title policies could affect earnings significantly.

14 March 2014

12

Barclays | U.S. Consumer Finance

IMPORTANT DISCLOSURES CONTINUED

First American Financial (FAF)
USD 27.36 (13-Mar-2014) Rating and Price Target Chart - USD (as of 13-Mar-2014)
36

Stock Rating OVERWEIGHT Currency=USD Date 07-Jan-2014 25-Oct-2013 Closing Price 27.55 25.48 22.44 21.59 23.80 22.80 15.97 Overweight Rating

Industry View POSITIVE

Adjusted Price Target 33.00 29.00 28.00 26.00 28.00 18.00 17.00

33

30

26-Jul-2013 10-Jul-2013 19-Dec-2012 09-Oct-2012 28-Jul-2011

27

24

21

Source: Thomson Reuters, Barclays Research
18

15

Historical stock prices and price targets may have been adjusted for stock splits and dividends.

12

9 Jul- 2011 Jan- 2012 Closing Price Jul- 2012 Jan- 2013 Jul- 2013 Rating Change Jan- 2014

Target Price

Source: IDC, Barclays Research

Link to Barclays Live for interactive charting
C: Barclays Bank PLC and/or an affiliate is a market-maker and/or liquidity provider in equity securities issued by First American Financial or one of its affiliates. D: Barclays Bank PLC and/or an affiliate has received compensation for investment banking services from First American Financial in the past 12 months. J: Barclays Bank PLC and/or an affiliate trades regularly in the securities of First American Financial. K: Barclays Bank PLC and/or an affiliate has received non-investment banking related compensation from First American Financial within the past 12 months. L: First American Financial is, or during the past 12 months has been, an investment banking client of Barclays Bank PLC and/or an affiliate. M: First American Financial is, or during the past 12 months has been, a non-investment banking client (securities related services) of Barclays Bank PLC and/or an affiliate. N: First American Financial is, or during the past 12 months has been, a non-investment banking client (non-securities related services) of Barclays Bank PLC and/or an affiliate. O: Barclays Capital Inc., through Barclays Market Makers, is a Designated Market Maker in First American Financial stock, which is listed on the New York Stock Exchange. At any given time, its associated Designated Market Maker may have "long" or "short" inventory position in the stock; and its associated Designated Market Maker may be on the opposite side of orders executed on the floor of the New York Stock Exchange in the stock. Valuation Methodology: Our $33 price target is reached by applying a 12x multiple to our normalized EPS estimate of $4.02 and discounting it at a 10% cost of equity over a 5 year time horizon until normalized earnings are reached. Risks which May Impede the Achievement of the Barclays Research Price Target: Economic risk: home price appreciation, mortgage rates, unemployment, and availabilty of mortgage credit impact the level of home sales and refinancing, which in turn affect FAF's earnings. Claim loss risks: claim losses associated with issuing title policies could affect earnings significantly.

14 March 2014

13

Barclays | U.S. Consumer Finance

IMPORTANT DISCLOSURES CONTINUED

MGIC Investment (MTG)
USD 8.63 (13-Mar-2014) Rating and Price Target Chart - USD (as of 13-Mar-2014)

Stock Rating OVERWEIGHT Currency=USD Date Closing Price 8.39 5.48 5.34 0.84 2.37 6.00 Overweight Rating

Industry View POSITIVE

Adjusted Price Target 11.00 9.00 8.00 1.00 3.00 7.00

12

24-Jan-2014 29-Apr-2013 05-Mar-2013 03-Aug-2012 09-Sep-2011 15-Jul-2011

10

8

6

Source: Thomson Reuters, Barclays Research Historical stock prices and price targets may have been adjusted for stock splits and dividends.

4

2

0

Jul- 2011

Jan- 2012 Closing Price

Jul- 2012

Jan- 2013

Jul- 2013 Rating Change

Jan- 2014

Target Price

Source: IDC, Barclays Research

Link to Barclays Live for interactive charting
A: Barclays Bank PLC and/or an affiliate has been lead manager or co-lead manager of a publicly disclosed offer of securities of MGIC Investment in the previous 12 months. C: Barclays Bank PLC and/or an affiliate is a market-maker and/or liquidity provider in equity securities issued by MGIC Investment or one of its affiliates. D: Barclays Bank PLC and/or an affiliate has received compensation for investment banking services from MGIC Investment in the past 12 months. J: Barclays Bank PLC and/or an affiliate trades regularly in the securities of MGIC Investment. L: MGIC Investment is, or during the past 12 months has been, an investment banking client of Barclays Bank PLC and/or an affiliate. Valuation Methodology: Our price target assumes the shares trade to about 10x our 2015 EPS estimate of $0.96. We add back the Present Value of MTG's Deferred Tax Asset, ~$1, to reach our $11 target. Risks which May Impede the Achievement of the Barclays Research Price Target: Credit Risk: Potential credit losses could affect earnings negatively. Non-prime mortgages tend to have higher delinquency rates than prime-quality mortgages. Cancellation Risk: Fast appreciation of home prices and refinancing of existing mortgages may lead to cancellation of private mortgage insurance and thus cessation of premium income.

14 March 2014

14

Barclays | U.S. Consumer Finance

IMPORTANT DISCLOSURES CONTINUED

Radian Group (RDN)
USD 15.18 (13-Mar-2014) Rating and Price Target Chart - USD (as of 13-Mar-2014)
20

Stock Rating OVERWEIGHT Currency=USD Date 06-Feb-2014 25-Jul-2013 05-Mar-2013 02-Nov-2012 09-Sep-2011 15-Jul-2011 Closing Price 15.20 14.07 10.49 5.38 2.84 4.06 Overweight Rating

Industry View POSITIVE

Adjusted Price Target 18.00 15.00 14.00 4.00 3.00 6.00

18

16

14

12

10

Source: Thomson Reuters, Barclays Research Historical stock prices and price targets may have been adjusted for stock splits and dividends.

8

6

4

2

0 Jul- 2011 Jan- 2012 Closing Price Jul- 2012 Jan- 2013 Jul- 2013 Rating Change Jan- 2014

Target Price

Source: IDC, Barclays Research

Link to Barclays Live for interactive charting
C: Barclays Bank PLC and/or an affiliate is a market-maker and/or liquidity provider in equity securities issued by Radian Group or one of its affiliates. J: Barclays Bank PLC and/or an affiliate trades regularly in the securities of Radian Group. K: Barclays Bank PLC and/or an affiliate has received non-investment banking related compensation from Radian Group within the past 12 months. N: Radian Group is, or during the past 12 months has been, a non-investment banking client (non-securities related services) of Barclays Bank PLC and/or an affiliate. O: Barclays Capital Inc., through Barclays Market Makers, is a Designated Market Maker in Radian Group stock, which is listed on the New York Stock Exchange. At any given time, its associated Designated Market Maker may have "long" or "short" inventory position in the stock; and its associated Designated Market Maker may be on the opposite side of orders executed on the floor of the New York Stock Exchange in the stock. Valuation Methodology: Our price target assumes the shares trade to about 10x our 2015 EPS estimate of $1.63 and adds back ~$2, which is the estimated Present Value of RDN's Deferred Tax Asset Risks which May Impede the Achievement of the Barclays Research Price Target: Credit Risk: Potential credit losses could affect earnings negatively. Non-prime mortgages tend to have higher delinquency rates than prime-quality mortgages. Credit losses could also negatively affect earnings in Radian's municipal bond insurance and reinsurance business. Cancellation Risk: Fast appreciation of home prices and refinancing of existing mortgages may lead to cancellation of private mortgage insurance and thus cessation of premium income.

14 March 2014

15

DISCLAIMER: This publication has been prepared by the Corporate and Investment Banking division of Barclays Bank PLC and/or one or more of its affiliates (collectively and each individually, "Barclays"). It has been issued by one or more Barclays legal entities within its Corporate and Investment Banking division as provided below. It is provided to our clients for information purposes only, and Barclays makes no express or implied warranties, and expressly disclaims all warranties of merchantability or fitness for a particular purpose or use with respect to any data included in this publication. Barclays will not treat unauthorized recipients of this report as its clients. Prices shown are indicative and Barclays is not offering to buy or sell or soliciting offers to buy or sell any financial instrument. Without limiting any of the foregoing and to the extent permitted by law, in no event shall Barclays, nor any affiliate, nor any of their respective officers, directors, partners, or employees have any liability for (a) any special, punitive, indirect, or consequential damages; or (b) any lost profits, lost revenue, loss of anticipated savings or loss of opportunity or other financial loss, even if notified of the possibility of such damages, arising from any use of this publication or its contents. Other than disclosures relating to Barclays, the information contained in this publication has been obtained from sources that Barclays Research believes to be reliable, but Barclays does not represent or warrant that it is accurate or complete. Barclays is not responsible for, and makes no warranties whatsoever as to, the content of any third-party web site accessed via a hyperlink in this publication and such information is not incorporated by reference. The views in this publication are those of the author(s) and are subject to change, and Barclays has no obligation to update its opinions or the information in this publication. The analyst recommendations in this publication reflect solely and exclusively those of the author(s), and such opinions were prepared independently of any other interests, including those of Barclays and/or its affiliates. This publication does not constitute personal investment advice or take into account the individual financial circumstances or objectives of the clients who receive it. The securities discussed herein may not be suitable for all investors. Barclays recommends that investors independently evaluate each issuer, security or instrument discussed herein and consult any independent advisors they believe necessary. The value of and income from any investment may fluctuate from day to day as a result of changes in relevant economic markets (including changes in market liquidity). The information herein is not intended to predict actual results, which may differ substantially from those reflected. Past performance is not necessarily indicative of future results. This material has been issued and approved for distribution in the UK and European Economic Area (“EEA”) by Barclays Bank PLC. It is being made available primarily to persons who are investment professionals as that term is defined in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005. It is directed at, and therefore should only be relied upon by, persons who have professional experience in matters relating to investments. The investments to which it relates are available only to such persons and will be entered into only with such persons. Barclays Bank PLC is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority and is a member of the London Stock Exchange. The Corporate and Investment Banking division of Barclays undertakes U.S. securities business in the name of its wholly owned subsidiary Barclays Capital Inc., a FINRA and SIPC member. Barclays Capital Inc., a U.S. registered broker/dealer, is distributing this material in the United States and, in connection therewith accepts responsibility for its contents. Any U.S. person wishing to effect a transaction in any security discussed herein should do so only by contacting a representative of Barclays Capital Inc. in the U.S. at 745 Seventh Avenue, New York, New York 10019. Non-U.S. persons should contact and execute transactions through a Barclays Bank PLC branch or affiliate in their home jurisdiction unless local regulations permit otherwise. Barclays Bank PLC, Paris Branch (registered in France under Paris RCS number 381 066 281) is regulated by the Autorité des marchés financiers and the Autorité de contrôle prudentiel. Registered office 34/36 Avenue de Friedland 75008 Paris. This material is distributed in Canada by Barclays Capital Canada Inc., a registered investment dealer and member of IIROC (www.iiroc.ca). Subject to the conditions of this publication as set out above, the Corporate & Investment Banking Division of Absa Bank Limited, an authorised financial services provider (Registration No.: 1986/004794/06. Registered Credit Provider Reg No NCRCP7), is distributing this material in South Africa. Absa Bank Limited is regulated by the South African Reserve Bank. This publication is not, nor is it intended to be, advice as defined and/or contemplated in the (South African) Financial Advisory and Intermediary Services Act, 37 of 2002, or any other financial, investment, trading, tax, legal, accounting, retirement, actuarial or other professional advice or service whatsoever. Any South African person or entity wishing to effect a transaction in any security discussed herein should do so only by contacting a representative of the Corporate & Investment Banking Division of Absa Bank Limited in South Africa, 15 Alice Lane, Sandton, Johannesburg, Gauteng 2196. Absa Bank Limited is a member of the Barclays group. In Japan, foreign exchange research reports are prepared and distributed by Barclays Bank PLC Tokyo Branch. Other research reports are distributed to institutional investors in Japan by Barclays Securities Japan Limited. Barclays Securities Japan Limited is a joint-stock company incorporated in Japan with registered office of 6-10-1 Roppongi, Minato-ku, Tokyo 106-6131, Japan. It is a subsidiary of Barclays Bank PLC and a registered financial instruments firm regulated by the Financial Services Agency of Japan. Registered Number: Kanto Zaimukyokucho (kinsho) No. 143. Barclays Bank PLC, Hong Kong Branch is distributing this material in Hong Kong as an authorised institution regulated by the Hong Kong Monetary Authority. Registered Office: 41/F, Cheung Kong Center, 2 Queen's Road Central, Hong Kong. Information on securities/instruments that trade in Taiwan or written by a Taiwan-based research analyst is distributed by Barclays Capital Securities Taiwan Limited to its clients. The material on securities/instruments not traded in Taiwan is not to be construed as 'recommendation' in Taiwan. Barclays Capital Securities Taiwan Limited does not accept orders from clients to trade in such securities. This material may not be distributed to the public media or used by the public media without prior written consent of Barclays. This material is distributed in South Korea by Barclays Capital Securities Limited, Seoul Branch. All equity research material is distributed in India by Barclays Securities (India) Private Limited (SEBI Registration No: INB/INF 231292732 (NSE), INB/INF 011292738 (BSE), Registered Office: 208 | Ceejay House | Dr. Annie Besant Road | Shivsagar Estate | Worli | Mumbai - 400 018 | India, Phone: + 91 22 67196363). Other research reports are distributed in India by Barclays Bank PLC, India Branch. Barclays Bank PLC Frankfurt Branch distributes this material in Germany under the supervision of Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin). This material is distributed in Malaysia by Barclays Capital Markets Malaysia Sdn Bhd. This material is distributed in Brazil by Banco Barclays S.A. This material is distributed in Mexico by Barclays Bank Mexico, S.A. Barclays Bank PLC in the Dubai International Financial Centre (Registered No. 0060) is regulated by the Dubai Financial Services Authority (DFSA). Principal place of business in the Dubai International Financial Centre: The Gate Village, Building 4, Level 4, PO Box 506504, Dubai, United Arab Emirates. Barclays

Bank PLC-DIFC Branch, may only undertake the financial services activities that fall within the scope of its existing DFSA licence. Related financial products or services are only available to Professional Clients, as defined by the Dubai Financial Services Authority. Barclays Bank PLC in the UAE is regulated by the Central Bank of the UAE and is licensed to conduct business activities as a branch of a commercial bank incorporated outside the UAE in Dubai (Licence No.: 13/1844/2008, Registered Office: Building No. 6, Burj Dubai Business Hub, Sheikh Zayed Road, Dubai City) and Abu Dhabi (Licence No.: 13/952/2008, Registered Office: Al Jazira Towers, Hamdan Street, PO Box 2734, Abu Dhabi). Barclays Bank PLC in the Qatar Financial Centre (Registered No. 00018) is authorised by the Qatar Financial Centre Regulatory Authority (QFCRA). Barclays Bank PLC-QFC Branch may only undertake the regulated activities that fall within the scope of its existing QFCRA licence. Principal place of business in Qatar: Qatar Financial Centre, Office 1002, 10th Floor, QFC Tower, Diplomatic Area, West Bay, PO Box 15891, Doha, Qatar. Related financial products or services are only available to Business Customers as defined by the Qatar Financial Centre Regulatory Authority. This material is distributed in the UAE (including the Dubai International Financial Centre) and Qatar by Barclays Bank PLC. This material is distributed in Saudi Arabia by Barclays Saudi Arabia ('BSA'). It is not the intention of the publication to be used or deemed as recommendation, option or advice for any action (s) that may take place in future. Barclays Saudi Arabia is a Closed Joint Stock Company, (CMA License No. 09141-37). Registered office Al Faisaliah Tower, Level 18, Riyadh 11311, Kingdom of Saudi Arabia. Authorised and regulated by the Capital Market Authority, Commercial Registration Number: 1010283024. This material is distributed in Russia by OOO Barclays Capital, affiliated company of Barclays Bank PLC, registered and regulated in Russia by the FSFM. Broker License #177-11850-100000; Dealer License #177-11855-010000. Registered address in Russia: 125047 Moscow, 1st Tverskaya-Yamskaya str. 21. This material is distributed in Singapore by the Singapore branch of Barclays Bank PLC, a bank licensed in Singapore by the Monetary Authority of Singapore. For matters in connection with this report, recipients in Singapore may contact the Singapore branch of Barclays Bank PLC, whose registered address is One Raffles Quay Level 28, South Tower, Singapore 048583. Barclays Bank PLC, Australia Branch (ARBN 062 449 585, AFSL 246617) is distributing this material in Australia. It is directed at 'wholesale clients' as defined by Australian Corporations Act 2001. IRS Circular 230 Prepared Materials Disclaimer: Barclays does not provide tax advice and nothing contained herein should be construed to be tax advice. Please be advised that any discussion of U.S. tax matters contained herein (including any attachments) (i) is not intended or written to be used, and cannot be used, by you for the purpose of avoiding U.S. tax-related penalties; and (ii) was written to support the promotion or marketing of the transactions or other matters addressed herein. Accordingly, you should seek advice based on your particular circumstances from an independent tax advisor. © Copyright Barclays Bank PLC (2014). All rights reserved. No part of this publication may be reproduced in any manner without the prior written permission of Barclays. Barclays Bank PLC is registered in England No. 1026167. Registered office 1 Churchill Place, London, E14 5HP. Additional information regarding this publication will be furnished upon request.

US08-000001